Literature DB >> 16669609

Endogenous histamine and cortisol levels in subjects with different histamine N-methyltransferase C314T genotypes : a pilot study.

Yuen Yi Hon1, William J Jusko, Hong-Hao Zhou, Guo-Lin Chen, Dong Guo, Gan Zhou, Vicky E Spratlin, Michael W Jann.   

Abstract

BACKGROUND: Histamine N-methyltransferase (HNMT) catalyzes the methylation of histamine and plays an important role in histamine biotransformation in bronchial epithelium. Enzymatic activity of HNMT has been shown to be regulated by genetic factors, including polymorphisms in the HNMT gene. In this pilot study we determined endogenous levels of histamine and cortisol in plasma and whole blood samples from subjects with different genotypes for the HNMT C314T polymorphism, and investigated whether these parameters differed between individuals with the HNMT CC genotype and those with the CT genotype.
METHODS: Blood samples were collected from 48 unrelated volunteers (36 males, 12 females), aged 21-40 years, who participated in the study. PCR-restriction fragment length polymorphism analysis was used to determine HNMT C314T genotypes. Erythrocyte HNMT activity was determined as well as plasma and whole blood levels of histamine and cortisol. Two-group comparisons of the various parameters were analyzed by Blocked Wilcoxon test and Wilcoxon Rank Sum test as appropriate.
RESULTS: Thirty-seven subjects (24 Caucasians, three African Americans, one Middle Eastern, five Indians, three Chinese, and one Filipino) were found to have the homozygous CC genotype. Ten subjects (eight Caucasians, one Middle Eastern, and one Chinese) were heterozygous and one individual (Pakistani) was homozygous for the variant 314T allele. The frequency of HNMT CT heterozygotes in the small Caucasian cohort was 0.125. Median enzyme activity was significantly lower in subjects with the heterozygous CT genotype than in those with the homozygous CC genotype (485 vs 631 U/mL of red blood cells; p=0.023). A broad range of histamine levels in plasma and whole blood was observed for all subjects. Whereas the median plasma histamine level was found to be higher in heterozygotes for the wild-type 314C allele than homozygotes (3.32 vs 2.30 nmol/L; p=0.021), there was no difference between the two groups in histamine levels in whole blood. Cortisol levels were similar between individuals with the homozygous CC genotype and those with the heterozygous CT genotype.
CONCLUSION: Wide variability of plasma and whole-blood histamine levels was observed in subjects with different HNMT C314T genotypes. Endogenous levels of histamine are likely to be affected by various genes and polymorphisms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16669609      PMCID: PMC4178529          DOI: 10.1007/BF03256450

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN: 1177-1062            Impact factor:   4.074


  19 in total

1.  Histamine N-methyltransferase pharmacogenetics: association of a common functional polymorphism with asthma.

Authors:  L Yan; R E Galinsky; J A Bernstein; S B Liggett; R M Weinshilboum
Journal:  Pharmacogenetics       Date:  2000-04

2.  Pharmacogenetics of N-methylation: heritability of human erythrocyte histamine N-methyltransferase activity.

Authors:  M C Scott; J A Van Loon; R M Weinshilboum
Journal:  Clin Pharmacol Ther       Date:  1988-03       Impact factor: 6.875

3.  Human histamine N-methyltransferase pharmacogenetics: common genetic polymorphisms that alter activity.

Authors:  C V Preuss; T C Wood; C L Szumlanski; R B Raftogianis; D M Otterness; B Girard; M C Scott; R M Weinshilboum
Journal:  Mol Pharmacol       Date:  1998-04       Impact factor: 4.436

4.  Suppression of histamine-induced adrenocorticotropic hormone release by antihistamines and antidepressants.

Authors:  M A Reilly; E B Sigg
Journal:  J Pharmacol Exp Ther       Date:  1982-09       Impact factor: 4.030

5.  Changes in plasma adrenocorticotropic hormone and cortisol levels induced by intracerebroventricular injection of histamine and its related compounds in dogs.

Authors:  S Tsujimoto; C Kamei; T Yoshida; K Tasaka
Journal:  Pharmacology       Date:  1993-08       Impact factor: 2.547

6.  Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties.

Authors:  R M Weinshilboum; F A Raymond; P A Pazmiño
Journal:  Clin Chim Acta       Date:  1978-05-02       Impact factor: 3.786

7.  Genetic segregation analysis of red blood cell (RBC) histamine N-methyltransferase (HNMT) activity.

Authors:  R A Price; M C Scott; R M Weinshilboum
Journal:  Genet Epidemiol       Date:  1993       Impact factor: 2.135

8.  Analysis of cortisol, methylprednisolone, and methylprednisolone hemisuccinate. Absence of effects of troleandomycin on ester hydrolysis.

Authors:  W F Ebling; S J Szefler; W J Jusko
Journal:  J Chromatogr       Date:  1984-02-10

9.  Histamine genomics in silico: polymorphisms of the human genes involved in the synthesis, action and degradation of histamine.

Authors:  Peter Igaz; Carlos P Fitzimons; Csaba Szalai; András Falus
Journal:  Am J Pharmacogenomics       Date:  2002

10.  Histaminergic activation of the hypothalamic-pituitary-adrenal axis.

Authors:  A Kjaer; P J Larsen; U Knigge; J Warberg
Journal:  Endocrinology       Date:  1994-09       Impact factor: 4.736

View more
  2 in total

1.  Genetic Variation along the Histamine Pathway in Children with Allergic versus Nonallergic Asthma.

Authors:  Sara Anvari; Carrie A Vyhlidal; Hongying Dai; Bridgette L Jones
Journal:  Am J Respir Cell Mol Biol       Date:  2015-12       Impact factor: 6.914

2.  Genetic Variation in the Histamine Production, Response, and Degradation Pathway Is Associated with Histamine Pharmacodynamic Response in Children with Asthma.

Authors:  Bridgette L Jones; Catherine M T Sherwin; Xiaoxi Liu; Hongying Dai; Carrie A Vyhlidal
Journal:  Front Pharmacol       Date:  2017-01-04       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.